NCT02320981
- Conditions
- Deglutition Disorders, Digestive System Diseases, Eosinophilia, +16 more
- Locations
-
- Vanderbilt Children's Hospital Nashville, Tennessee, United States
Clinical trial condition
Eosinophilia
Explore clinical trials studying Eosinophilia. Study availability and eligibility vary by location and protocol.
264 public trials
42 recruiting studies
Eosinophilia trial results
Completed
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
NCT00635089
- Conditions
- Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
- Locations
-
- The Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Arizona Dept. of Pediatrics Tucson, Arizona, United States
- Arkansas Children's Hospital/University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Kaiser Permanente Hospital- Pediatric Gastroenterology Hayward, California, United States
NCT00171912
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +32 more
- Locations
-
- Novartis Investigative Site East Melbourne, Australia
Completed
A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021
NCT01498497
- Conditions
- Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
- Locations
-
- Children's Center for Digestive Health Atlanta, Georgia, United States
- Northwestern University School of Medicine Chicago, Illinois, United States
- Riley Hospital for Children Indianapolis, Indiana, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT02434029
- Conditions
- Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
- Locations
-
- Center for Digestive Diseases Eppendorf Hamburg, Germany
Completed
EoE(Eosinophilic Esophagitis)
NCT01999439
- Conditions
- Deglutition Disorders, Digestive System Diseases, Dysphagia, +14 more
- Locations
-
- University of Michigan C. S. Mott Childrens Hospital Ann Arbor, Michigan, United States
Completed
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
NCT00154388
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
- Locations
-
Not specified
NCT00538434
- Conditions
- Deglutition Disorders, Digestive System Diseases, Eosinophilia, +13 more
- Locations
-
- The Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Arizona Dept. of Pediatrics Tucson, Arizona, United States
- Arkansas Children's Hospital/University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Kaiser Permanente Hospital- Pediatric Gastroenterology Hayward, California, United States
NCT01508936
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Investigational Site 861 Birmingham, Alabama, United States
- Investigational Site 842 Homewood, Alabama, United States
- Investigational Site 887 Jasper, Alabama, United States
- Investigational Site 809 Tucson, Arizona, United States
NCT01270464
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Teva Investigational Site 12 Anaheim, California, United States
- Teva Investigational Site 11 Fountain Valley, California, United States
- Teva Investigational Site 43 Los Angeles, California, United States
- Teva Investigational Site 4 Orange, California, United States